Cargando…

Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of Maternal Risk Factors

Background. Hepatitis C virus (HCV) is an underappreciated cause of pediatric liver disease, most frequently acquired by vertical transmission (VT). Current guidelines that include the option of screening infants for HCV RNA at 1–2 months are based on data prior to current real-time polymerase chain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jhaveri, Ravi, Hashem, Mohamed, El-Kamary, Samer S., Saleh, Doa'a A., Sharaf, Sahar A., El-Mougy, Fatma, Abdelsalam, Lobna, Ehab, Mohamed, El-Ghazaly, Hesham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498289/ https://www.ncbi.nlm.nih.gov/pubmed/26180831 http://dx.doi.org/10.1093/ofid/ofv089

Ejemplares similares

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4
por: Shaker, Olfat, et al.
Publicado: (2013)

Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships
por: Hahn, Judith A, et al.
Publicado: (2019)

Hepatitis C Virus-Specific Cell-Mediated Immune Responses in Children Born to Mothers Infected with Hepatitis C Virus
por: El-Kamary, Samer S., et al.
Publicado: (2013)

Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
por: Habchi, Jackie, et al.
Publicado: (2020)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

Single Clinical Practice's Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV-Infected Mothers
por: Bal, Aswine, et al.
Publicado: (2016)

Implementing a Comprehensive Hepatitis C Virus (HCV) Clinic Within a Human Immunodeficiency Virus Clinic: A Model of Care for HCV Microelimination
por: Rizk, Christina, et al.
Publicado: (2019)

Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease
por: Katrak, Shereen, et al.
Publicado: (2016)

Highly Successful Hepatitis C Virus (HCV) Treatment Outcomes in Human Immunodeficiency Virus/HCV-Coinfected Patients at a Large, Urban, Ryan White Clinic
por: Patel, Manish, et al.
Publicado: (2017)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
por: Tabll, Ashraf, et al.
Publicado: (2011)

Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt
por: Paez Jimenez, Adela, et al.
Publicado: (2009)

Association of HCV with diabetes mellitus: an Egyptian case-control study
por: Elhawary, Eman I, et al.
Publicado: (2011)

Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy
por: Schulte, Benjamin, et al.
Publicado: (2020)

Dual versus triple therapy in treatment of hepatitis C virus (HCV)
por: Bishai, Nevine, et al.
Publicado: (2022)

Occult HCV infection in liver transplanted patients: frequency and consequences
por: Saad, Zeinab M, et al.
Publicado: (2022)

Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients
por: El-Emshaty, Wafaa M., et al.
Publicado: (2011)

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV
por: Hill, Kristi C, et al.
Publicado: (2022)

Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion
por: Chu, Carissa E., et al.
Publicado: (2016)

Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy
por: Ghiglione, Yanina, et al.
Publicado: (2020)

Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic
por: Sansom, Sarah E, et al.
Publicado: (2019)

Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification
por: Hedskog, Charlotte, et al.
Publicado: (2019)

Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
por: Garvey, Lucy J, et al.
Publicado: (2020)

Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients
por: Shoman, Sahar, et al.
Publicado: (2014)

Soluble egg antigen of Schistosoma Haematobium induces HCV replication in PBMC from patients with chronic HCV infection
por: El-Awady, Mostafa K, et al.
Publicado: (2006)

Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection
por: Collins, Lauren F, et al.
Publicado: (2017)

Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission
por: Daw, Mohamed A, et al.
Publicado: (2015)

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1
por: Berenguer, Juan, et al.
Publicado: (2019)

Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation
por: Salman, Ahmed, et al.
Publicado: (2021)

Characterization of chronic HCV infection-induced apoptosis
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2011)

Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma
por: El-Mougy, Fatma A., et al.
Publicado: (2014)

Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
por: Khattab, Mahmoud A., et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease
por: Gaafar, Ahmed E., et al.
Publicado: (2019)

Seroprevalence of HBV, HCV & HIV Co-Infection and Risk Factors Analysis in Tripoli-Libya
por: Daw, Mohamed A., et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Correction to: Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease
por: Gaafar, Ahmed E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a6i0opq6diqafsihk5efg95rjt